Latest Surrozen News & Updates

See the latest news and media coverage for Surrozen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Surrozen

Biotechnology company developing Wnt-based regenerative therapies

surrozen.com

Headquarters: South San Francisco, United States
Company type: Private company
Number of employees: 10–70

Last updated Today

Latest news about Surrozen

In short: Surrozen formed a strategic research collaboration for idiopathic pulmonary fibrosis and advanced its ophthalmology pipeline toward IND submission.

Company announcements

May 6 Surrozen

Surrozen reports Q1 2026 financial results

Cash at $106.9M. On track for SZN-8141 IND submission H2 2026. Net loss $127.5M.

March 23 Surrozen

Surrozen reports Q4 and full-year 2025 financial results

Pipeline advances with IND submission for SZN-8141 planned for H2 2026. Receives $5M milestone from Boehringer Ingelheim. Strengthens leadership. Cash at $89.2M; net loss $242M.

7 November 2025 Surrozen

Surrozen reports Q3 2025 financial results

Cash stands at $81.3M. Appoints Andrew Maleki as CFO. Advances ophthalmology pipeline with IND for SZN-8141 planned in 2026.

8 August 2025 Surrozen

Surrozen reports Q2 2025 financial results

Appoints Daniel Chao as VP of Clinical Development, forms Clinical Advisory Board, progresses ophthalmology pipeline, reports $90.4M cash.

Media coverage

June 16 Stockhouse

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

Research collaboration to leverage Surrozen&CloseCurlyQuote;s antibody research capabilities and expertise to discover a potential first in class treatment for patients with Idiopathic Pulmonary Fibrosis SOUTH...

May 30 The Globe and Mail

Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update

Surrozen remains focused on advancing a new generation of ophthalmology therapeutics that are built on a foundation of Wnt pathway biology. Surrozen's pipeline leverages its...

May 17 Yahoo Finance

We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Rate

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or...

May 6 Markets Insider

Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update

On track to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of 2026Well-capitalized with $106.9 million in...

Never miss news about Surrozen

Track Surrozen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.